Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacy Practice Management Quarterly|June 6, 1998
The pharmacoeconomics of high-cost biotechnology productsW J Dana, K Farthing
Hospital Formulary|September 1, 1994
Managing high cost and biotech drugs: two institutions' perspectivesW J Dana, B McWhinney
Clinical Pharmacy|March 1, 1990
Ifosfamide and mesnaS E Schoenike, W J Dana
Hospital Formulary|June 1, 1990
Formulary decision making in a specialty hospital: effective management of potent and costly drug therapiesM J Keating, W J Dana
Contemporary Pharmacy Practice|February 5, 1981
Human serum albumin usage in a comprehensive cancer centerL Forrester, R Ballentine, W J Dana
American Journal of Hospital Pharmacy|April 1, 1978
Drug information services in an oncology institutionW J Dana, R Ballentine, C Gamble, et al.
Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1985
Genotoxic classification of anticancer drugsT S Matney, T V Nguyen, T H Connor, et al.
American Journal of Hospital Pharmacy|November 1, 1982
Risk of handling injectable antineoplastic agentsR W Anderson, W H Puckett, W J Dana, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
Pageof 1